Announcement on Obtaining Drug Registration Certificate
Filed with SSE · · 3 pages · Chinese
Shanghai Shyndec Pharmaceutical Co., Ltd. on 6ix
Earlier from Shanghai Shyndec Pharmaceutical
- Announcement on the Wholly-owned Subsidiary's Drug Passing Generic Drug Consistency Evaluation
- Semi-annual Performance Forecast for 2026
- Announcement on Resolutions of the 5th Meeting of the 9th Board of Directors
- Announcement on Holding Subsidiary Obtaining Drug Registration Certificate
- Announcement on Obtaining Drug Registration Certificate by Subsidiary
Later from Shanghai Shyndec Pharmaceutical
- Announcement on Obtaining Drug Registration Certificate by Wholly-owned Subsidiary
- Announcement on Progress of Signing of the "Drug Marketing Authorization Transfer Contract" by a Controlled Subsidiary
- Announcement on Resolutions of the 6th Meeting of the 9th Board of Directors
- Announcement on Wholly-owned Sub-subsidiary Obtaining Approval for Marketing of Chemical APIs
- Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
Follow Shanghai Shyndec Pharmaceutical into a list and get an email when it puts out news.
Follow Shanghai Shyndec Pharmaceutical